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Abstract
Background: The optimal distribution between physical activity (PA) levels and sedentary behaviour (SB) for the
greatest benefits for body composition among older adults with overweight/obesity and chronic health conditions
remains unclear. We aimed to determine the prospective association between changes in PA and in SB with
concurrent changes in body composition and to examine whether reallocating inactive time into different physical
activity levels was associated with 12-month change to body composition in older adults.
Methods: Longitudinal assessment nested in the PREDIMED-Plus trial. A subsample (n = 1564) of men and women
(age 55–75 years) with overweight/obesity and metabolic syndrome from both arms of the PREDIMED-Plus trial was
included in the present analysis. Participants were followed up at 6 and 12 months. Physical activity and SB were
assessed using validated questionnaires. Out of 1564 participants, 388 wore an accelerometer to objectively
measure inactive time and PA over a 7-day period. At each time point, participants’ body composition was
measured using dual-energy X-ray absorptiometry (DXA). Standard covariate-adjusted and isotemporal substitution
modelling were applied to linear mixed-effects models.
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Results: Increasing 30 min of total PA and moderate-to-vigorous physical activity (MVPA) was associated with
significant reductions in body fat (β − 0.07% and − 0.08%) and visceral adipose tissue (VAT) (− 13.9 g, and − 15.6 g)
at 12 months (all p values < 0.001). Reallocating 30 min of inactive time to MVPA was associated with reductions in
body fat and VAT and with an increase in muscle mass and muscle-to-fat mass ratio (all p values < 0.001).
Conclusions: At 12 months, increasing total PA and MVPA and reducing total SB and TV-viewing SB were
associated with improved body composition in participants with overweight or obesity, and metabolic syndrome.
This was also observed when substituting 30 min of inactive time with total PA, LPA and MVPA, with the greatest
benefits observed with MVPA.
Trial registration: International Standard Randomized Controlled Trial (ISRCTN), 89898870. Retrospectively
registered on 24 July 2014
Keywords: Physical activity, Sedentary behaviour, Body composition, Visceral adipose tissue, Isotemporal
substitution
Background
The relationship between physical activity (PA), seden-
tary behaviour (SB) and markers of obesity and body
composition has been researched extensively in the
literature [1–5]. However, a beneficial combination be-
tween SB and PA at different intensity levels for the
greatest benefits for body composition among older
adults with overweight and obesity remains unclear [1,
6–10]. Up-to-date, only a few studies have been con-
ducted in older adults with chronic conditions [4, 11],
and scarce research has used longitudinal or objectively
measured data [8, 12–15].
Age-related changes in body composition include a
decline in muscle mass and the accumulation of fat in
central body regions [16], leading to physical impairment
and morbidity. Greater visceral adipose tissue (VAT)
seems to play a particular role in the development of
chronic diseases, such as insulin resistance, type 2 dia-
betes (T2D) and cardiovascular disease (CVD) [12, 17,
18]. Understanding how increases in PA and reductions
in SB may minimize the adverse effects of ageing on
body composition would shed light as to what are the
best strategies to help improve health and quality of life
in older people.
Different PA dimensions (mode, frequency, duration
and intensity) may affect body composition differently,
depending partly on SB displacement. Isotemporal sub-
stitution models (ISMs) have been recommended as one
of the most appropriate statistical analysis to explore the
associations between reallocating activity patterns (time
spent in PA and SB) and health outcomes, taking into
account the finite concept of time (24 h/day) [19, 20].
Scarce research using ISM to explore the associations
between activity patterns and body composition has
been conducted in elderly cohorts, and most research
had been conducted using a cross-sectional design [21,
22] or used anthropometry to assess body composition
[15]. Therefore, studies using device-based longitudinal
measures for activity patterns and regional body com-
position are warranted.
This novel study aimed to provide new evidence about
the associations between SB and PA with directly quan-
tified body composition in an ageing population with
metabolic syndrome, using a longitudinal study design.
The specific objectives of the present study were (a) to
determine the association of concurrent changes in self-
reported PA levels and SB with body composition
changes measured with dual-energy X-ray absorpti-
ometry (DXA) at 12 months follow-up and (b) to assess
the impact of replacing accelerometer-derived inactive
time (IT) data, as a proxy measure of SB, with PA at dif-
ferent intensities and with time in bed, on body compos-
ition changes.
Methods
Study overview and sample
The present study reports an observational prospective
assessment nested in the PREDIMED-Plus study (Spain).
This clinical trial aims to prevent CVD in older adults
and has been described elsewhere [23, 24]. In brief, men
(55–75 years) and women (60–75 years), with a body
mass index (BMI) ≥ 27 and < 40 kg/m2 and ≥ 3 compo-
nents of the metabolic syndrome (MetS) were eligible
[25]. Participants were recruited into the study between
2013 and 2016 and were randomized into control or
intervention arm. Members of the same households were
randomized by clusters, with the couple as the unit of
randomization. Participants in the intervention arm re-
ceived a multicomponent weight loss intervention, based
on an energy-restricted traditional Mediterranean diet
(erMedDiet), PA promotion and behavioural support.
Those in the control group received recommendations
about an unrestricted caloric Mediterranean diet and
usual care without advices on energy restriction, PA and
weight loss objective [24] (the trial is still ongoing) (for
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further information, please visit http://www.predimed-
plus.com/).
Longitudinal data collected at baseline, 6 and 12months
from a subsample of 1564 participants from the PREDIM
ED-Plus trial (total sample 6874), recruited across 7 cen-
tres, of both control and intervention arms, were included
in this analysis. Figure 1 shows the number of participants
at each time point. All participants provided written in-
formed consent. The study’s protocol was approved by the
Research Ethics Committees from all recruiting centres
according to the ethical standards of the Declaration of
Helsinki. The trial was registered at the International
Standard Randomized Controlled Trial (ISRCTN: http://
www.isrctn.com/ISRCTN89898870). The study’s longitu-
dinal database generated on March 25, 2019, was used for
this analysis.
Exposure assessment
Self-reported physical activity and sedentary behaviours
Leisure-time PA performed during a conventional
month was assessed using the validated self-reported
REGICOR questionnaire [26]. Time spent on SB over
the last year was measured using the validated self-
reported Nurses’ Health Study questionnaire [27]. Time
spent in PA was calculated as a product of the frequency
and duration of 6 types of activities categorized into
three intensities: light PA (LPA) (< 4 Metabolic Equiva-
lent Tasks (METs))—walking at a slow/normal pace;
moderate PA (4–5.5 METs)—brisk walking and
gardening; and vigorous PA (≥ 6.0 METs)—walking in
the countryside, climbing stairs, exercise or playing
sports [28]. Moderate-to-vigorous PA (MVPA) was cal-
culated as the sum of moderate and vigorous PA, and
total PA was determined by adding up all the activities.
Time spent in total SB (counting the number of hours
per day spent in a seated position) and in TV viewing
was calculated as the sum of time spent in each activity
during weekdays*5 and weekend-days*2. Data for these
questionnaires were collected by trained interviewers in
all time points. Questionnaire results are analysed in ac-
cumulated increments of 30 min/day.
Accelerometer measured physical activity and inactive time
Inactive time, used as a proxy measure for sedentary
time, is defined as any activity that requires less than 1.5
METs during waking hours. Participants were asked to
wear an accelerometer (GENEActiv, ActivInsights Ltd.,
Kimbolton, UK) on their non-dominant wrist continu-
ously for 7 days. Data extracted from the GENEActiv
were examined as 1-min epochs of IT (< 1.5 METs),
LPA (1.5–3 METs), MVPA (> 3 METs) and time in bed
(time difference between going to bed and leaving) [29–
31]. Details of how the PA and IT were processed have
been described [32] previously. Accelerometer measures
were taken at baseline, 6- and 12-months follow-up. Ac-
celerometer results are presented in accumulated incre-
ments of 30 min/day.
Fig. 1 Flow chart of the study sample. DXA dual-energy X-ray absorptiometry, PA physical activity, SB sedentary behaviour, VAT visceral
adipose tissue
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Outcome assessment
Body composition
Baseline and 6 and 12 months follow-up data of total
and regional body composition were taken using third-
generation DXA scanners from GE Healthcare (Madi-
son, WI, USA), using the EnCore™ software. Total body
fat mass and total body muscle mass were expressed as
the percentage of DXA-derived total body mass (sum of
total bone, fat and muscle mass (g)). VAT was deter-
mined using the validated CoreScan software application
[33]. The muscle-to-fat mass ratio was calculated divid-
ing the total muscle mass (g) by the total fat mass (g)
and multiplied by 100. DXA scans were performed by
trained operators following a standard protocol and sub-
ject positioning provided by the manufacturer. DXA
scanners were phantom calibrated daily according to the
manufacturer’s guidelines.
Other covariates
Baseline data for sex, age, smoking habits (categorized as
never, current or former), educational level (categorized
as higher education/technician, secondary education or
not-completed primary education/primary education),
medical conditions (T2D) and medication use (antidia-
betic treatment) were self-reported. Body weight (kg)
and height (m) were measured in light clothing and
without shoes using a calibrated scale and a wall-
mounted stadiometer, respectively. Weight and height
were measured twice, and the mean value was used in
the analysis. Glycated haemoglobin (HbA1c, %) was de-
termined using standard biochemical analyses with
blood samples collected after an overnight fast. Type 2
diabetes was defined as meeting any of the following cri-
teria: self-reported diabetes at inclusion or baseline,
HbA1c ≥ 6.5% or use of antidiabetic medication at base-
line, such as insulin, metformin (in case of diagnosed
diabetes or HbA1c ≥ 6.5%) and other medication for dia-
betes. A validated food frequency questionnaire [34] and
the Spanish food composition tables [35] were used to
estimate total energy intake (kcal/day).
Statistical analyses
Characteristics of the study participants at baseline and
at follow-up are presented as mean and standard devia-
tions (SD) for continuous variables and absolute num-
bers (percentages) for categorical variables.
Main analyses were run in completers-only. Linear
mixed-effects models with random intercepts at recruit-
ing centre, family and patient levels were used to explore
the associations between concurrent changes in self-
reported PA (total, light and moderate-to-vigorous, in
accumulated increments of 30 min/day) and SB (total
and TV viewing, in accumulated increments of 30 min/
day) with body composition changes (percentage of body
fat, percentage of muscle mass, g of VAT) at 12 months
follow-up. Changes in repeatedly measured variables
were calculated as the difference between the results
from each follow-up assessment (changes from 0 to 6
months follow-up and from 6 to 12months follow-up).
Firstly, minimally adjusted models were run controlling
for age (years), sex, intervention arm (intervention or
control group) and follow-up point (months).
Multivariable-adjusted models were further adjusted for
baseline variables, such as educational level, smoking
status, T2D (all categorical) and height (m), as well as
changes in repeatedly measured total energy intake
(kcal/day), total PA (30 min/day accumulated incre-
ments) for SB exposures, and total SB (30 min/day accu-
mulated increments) for PA exposures.
Analyses using objectively measured PA and IT in the
subsample of participants providing DXA scans and ac-
celerometer data (n = 388) were also performed. Linear
mixed-effects models using the ISM were used to ex-
plore the impact of replacing 30 min of IT by 30min of
time in bed, LPA or MVPA on body composition
changes at 12 months follow-up. These models were
performed with random intercepts at the recruiting
centre, family and patient levels. Prior to running the
minimally- and multivariable-adjusted models (the same
covariates as described above), all activity patterns at
baseline and 6 and 12months follow-up (time in bed,
IT, LPA and MVPA) were divided by 30, which was con-
sidered as the unit of time equivalent to 30min/day (ac-
cording to the PA guidelines [36–38]). To account for
the 24-h day finite time [20], a variable representing the
total accelerometer wear time was constructed by adding
up time in bed, IT, LPA and MVPA. This was entered
simultaneously in all ISMs. Analyses followed the pub-
lished guidelines for ISM [39]. Sensitivity analyses using
the last observation carried forward (LOCF) method
were used to estimate missing data at follow-up on both
exposure and outcome variables. Models were repeated
after excluding data measured at 6 months (due to a
high number of missing data). These analyses were also
performed in the subsample of participants (n = 388)
providing accelerometer data.
Lastly, potential effect modifications by sex (men or
women) were checked by adding an interaction term be-
tween sex and all exposures. Stratified analyses were
conducted when a significant interaction was detected
(p < 0.05). All analyses were conducted with the Stata
v15.0. program. All p values < 0.05 were deemed statisti-
cally significant.
Results
Table 1 shows the participants’ characteristics at baseline,
6 and 12months. On average, participants at baseline
were 65 years old, with a BMI of 32.5 kg/m2 and 48% were
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women. At 12months, participants (intervention and con-
trol groups) reduced their waist circumference, BMI and
total energy intake compared to baseline. At 6 and 12
months, participants accrued more total PA, LPA and
MVPA and less total and TV-viewing SB compared to
baseline. Reductions of percentage body fat and VAT and
increased percentage of muscle mass and muscle-to-fat
mass ratio were also observed at 12 months. Similar re-
sults were observed in those providing accelerometry data
(see Additional file 1: Table S1).
Table 2 shows the β coefficients (95% CIs) for the as-
sociations between concurrent changes in self-reported
leisure-time PA, self-reported SB (both per 30-min accu-
mulated increments) and body composition. After ad-
justment for potential confounders, increasing 30 min of
total PA was significantly associated with a decrease in
body fat (β − 0.07%, 95% CIs − 0.10; − 0.04%) and VAT
(− 13.9 g; − 21.5; − 6.23) and increased muscle mass
(0.07%; 0.04; 0.10) and muscle-to-fat mass ratio (0.41;
0.15; 0.67). Increases of 30 min of MVPA were linked to
significantly reduced body fat (− 0.08%, − 0.11; − 0.04%)
and VAT (− 15.6 g; − 24.1; − 7.25) and with increased
muscle mass (0.07%; 0.04; 0.10) and muscle-to-fat mass
ratio (0.44; 0.15; 0.72). Overall, 30 more minutes of total
and TV-viewing SB were associated with significantly
greater body fat and lower muscle mass. No significant
associations were observed for LPA.
Table 3 shows the β coefficients (95% CIs) for the
ISM; Fig. 2 shows the ISM with the changes in body
composition standardized as z-scores to aid comparabil-
ity. After adjusting for potential confounders, reallocat-
ing 30 min/day of IT with time in bed, LPA and MVPA
was associated with lower VAT (β − 23.8 g, − 11.2 g and
− 92.4 g) and body fat (β − 0.09%, − 0.13% and − 0.54%)
and with an increased muscle mass (β 0.08%, 0.12% and
0.51%) and muscle-to-fat mass ratio (β 0.89, 0.90 and
3.74), with the strongest associations seen in MVPA.
No major differences were observed when repeating
the models in the whole sample after replacing missing
data using the LOCF method (see Additional file 1:
Table S2). No significant differences were found when
repeating ISM in the subsample after replacing missing
data using the LOCF method (see Additional file 1:
Table S3). No major differences were found when linear
Table 1 Socio-demographic, lifestyle and body composition characteristics of participants at baseline, 6 and 12 months follow-up
Parameters Number Baseline, mean (SD) Number 6months, mean (SD) Number 12months, mean (SD)
Socio-demographic characteristics
Age (years) 1564 65.3 (5.0)
Sex, women, n (%) 1564 751 (48)
Type 2 diabetes, n (%) 1564 469 (30)
Height (m) 1564 1.63 (0.10)
Waist circumference (cm) 1564 107 (9.31) 1444 105 (9.52) 1404 105 (9.72)
Body mass index (kg/m2) 1564 32.5 (3.34) 1502 32.0 (3.49) 1496 31.8 (3.50)
Current smokers, n (%) 1564 197 (12.6)
Higher education, n (%) 1564 333 (21.3)
Total energy intake (kcal/day) 1564 2426 (581) 1428 2294 (467) 1400 2268 (454)
Lifestyle: physical activity and sedentary behaviour (self-reported)
Total PA (h/day) 1564 1.22 (1.01) 1447 1.40 (1.06) 1406 1.41 (1.06)
LPA (h/day) 1564 0.47 (0.56) 1447 0.48 (0.59) 1406 0.49 (0.59)
MVPA (h/day) 1564 0.76 (0.90) 1447 0.92 (0.96) 1406 0.92 (0.97)
Total SB (h/day) 1564 5.86 (1.86) 1446 5.63 (1.77) 1406 5.51 (1.75)
TV-viewing SB (h/day) 1564 3.12 (1.64) 1446 2.91 (1.52) 1406 2.87 (1.44)
Body composition determined by DXA
Percentage of body fat* 1564 40.5 (6.90) 1048 39.7 (7.06) 1234 39.6 (7.04)
VAT (kg) 1529 2.30 (0.89) 1035 2.17 (0.86) 1223 2.21 (0.88)
Percentage of muscle mass* 1564 56.5 (6.56) 1048 57.2 (6.70) 1234 57.2 (6.68)
Muscle-to-fat mass ratio** 1564 147 (44.1) 1048 152 (48.3) 1234 153 (48.1)
Values are mean (SD) for continuous variables, and n (percentage) for categorical variables
DXA dual-energy X-ray absorptiometry, VAT visceral adipose tissue, PA physical activity, LPA light physical activity, MVPA moderate-to-vigorous physical activity, SB
sedentary behaviour
*Percentage of body fat and percentage of muscle mass were calculated taking into account muscle mass, fat mass and bone mass measured with a whole-body
DXA scan
**Muscle-to-fat mass ratio was calculated as (total muscle mass in g/total fat mass in g) × 100
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mixed-effects models were performed in the subsample
providing accelerometer data (n = 388) (see Add-
itional file 1: Table S4). No modification effect by sex
was observed. The results were consistent after repeating
the models with completers only, excluding the 6
months’ data.
Discussion
Results from this longitudinal study suggest that increas-
ing total PA and MVPA were associated with an improved
body composition phenotype in a sample of older adults
with overweight or obesity and the MetS. Greater total SB
and, to a lesser extent, TV-viewing sedentary time were
Table 3 Isotemporal substitution of inactive time (30 min/day) with time in bed and physical activity measured with an
accelerometer in body composition changes: longitudinal analyses in completers-only
Percentage of body fat VAT (g) Percentage of muscle mass Muscle-to-fat mass ratio
β (95% CI) p value β (95% CI) p value β (95% CI) p value β (95% CI) p value
Inactive time with time in bed
Minimally-adjusted − 0.10 (− 0.20; 0.00) 0.051 − 26.9 (− 46.5; − 7.27) 0.007 0.09 (− 0.01; 0.19) 0.067 0.93 (0.03; 1.83) 0.042
Multivariable-adjusted − 0.09 (− 0.19; 0.01) 0.079 − 23.8 (− 43.3; − 4.27) 0.017 0.08 (− 0.02; 0.18) 0.097 0.89 (− 0.01; 1.79) 0.052
Inactive time with LPA
Minimally-adjusted − 0.13 (− 0.25; − 0.00) 0.044 − 11.8 (− 36.1; 12.6) 0.343 0.12 (0.00; 0.24) 0.046 0.87 (− 0.24; 1.97) 0.124
Multivariable-adjusted − 0.13 (− 0.25; − 0.00) 0.042 − 11.2 (− 35.4; 13.0) 0.363 0.12 (0.00; 0.25) 0.042 0.90 (− 0.20; 2.01) 0.110
Inactive time with MVPA
Minimally-adjusted − 0.53 (− 0.76; − 0.29) < 0.001 − 98.7 (− 146; − 52.0) < 0.001 0.50 (0.27; 0.73) < 0.001 3.51 (1.43; 5.60) 0.001
Multivariable-adjusted − 0.54 (− 0.78; − 0.31) < 0.001 − 92.4 (− 139; − 45.6) < 0.001 0.51 (0.28; 0.74) < 0.001 3.74 (1.64; 5.85) < 0.001
The values show the β coefficients (95% CIs). These represent the change in outcome variables when substituting 30 min/day of inactive time with time in bed
and physical activity. Isotemporal mixed-effects linear models with random intercepts at recruiting centre, family and patient level were used. Analyses included
only completers. Minimally-adjusted model: age, sex, intervention arm, time and total wear time. The multivariable-adjusted model was further adjusted for
baseline variables, such as educational level, smoking, diabetes, height, and repeatedly measured total energy intake. The n of each outcome at baseline was for
the percentage of body fat n = 388, for VAT n = 380, for the percentage of muscle mass n = 388 and for muscle-to-fat mass ratio n = 388; at 6 months was for the
percentage of body fat n = 262, for VAT n = 255, for the percentage of muscle mass n = 262 and for muscle-to-fat mass ratio n = 262; at 12 months was for the
percentage of body fat n = 303, for VAT n = 299, for the percentage of muscle mass n = 303 and for muscle-to-fat mass ratio n = 303
VAT visceral adipose tissue, LPA light physical activity, MVPA moderate-vigorous physical activity
Fig. 2 Isotemporal substitution of inactive time (30 min/day) with time in bed and physical activity on standardized body composition (z-score):
analyses in completers only. The values shown are β (95% CI). These represent the change in outcome variables (z-scores) when substituting 30
min/day of inactive time with time in bed and physical activity. Mixed-effects linear models with random intercepts at recruiting centre, family
and patient level were used to assess the isotemporal substitution of inactive time with time in bed, LPA and MVPA, adjusting for age, sex,
intervention arm, time, educational level, smoking, diabetes, height, repeatedly measured total energy intake and total wear time. LPA, light
physical activity; MVPA, moderate-to-vigorous physical activity; VAT, visceral adipose tissue. *p value < 0.05
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associated with a worsen body composition. Overall, this
study highlights that replacing 30min a day of IT with an
equal amount of MVPA, LPA and time in bed resulted in
significantly improved markers of body composition.
These findings are consistent with previous cross-
sectional research in adult populations [3, 32, 40], which
have found a hazardous relationship between SB and
markers of body composition, including body fat, VAT
and muscle mass [3, 9, 32, 40, 41]. The present results
showed that greater SB is associated with greater body fat
and lower muscle mass in an ageing population, resulting
in greater cardiometabolic risk and disability. In line with
our findings, other authors found that increasing total PA
and MVPA improve body composition [3, 8, 40] and re-
duce the accumulation of VAT [8, 10, 42, 43], yet no ef-
fects associated to LPA and body composition have been
reported with the present results based on self-reported
data.
Limited research using the ISM in older adults is avail-
able, and only isolated reports in general adult popula-
tions with chronic conditions, such as the MetS [44, 45],
or using data from DXA scans are available [32]. How-
ever, no research using the same methods as this study
in older adults has been found, limiting the opportun-
ities for comparison. The use of ISM makes it possible
to analyse the effect of substituting one behaviour for
another. This type of analysis allows a better under-
standing of the association between PA and sedentarism,
and health. It takes into account aspects of daily life,
such as the need to replace one behaviour with another
due to limited time (24 h/day). This is an important ad-
vantage to take into account, compared to other statis-
tical analyses. Cross-sectional research conducted in
adults (≥ 18 years) [46, 47] showed similar beneficial ef-
fects of replacing a unit of time spent inactive with equal
amounts of LPA, MVPA or sleep in body composition
markers using anthropometric measures. However, if
this relationship persists over time remains unclear.
Our results showed that replacing IT with LPA is associ-
ated with improved body composition changes (body fat
and muscle mass). However, the greatest changes in body
composition were observed replacing IT with MVPA, with
significant changes in all outcome variables (percentage of
body fat, VAT, percentage of muscle mass and muscle-to-
fat mass ratio, p value < 0.001). Similar results have been
observed in previous cross-sectional research in adults [32]
and in longitudinal studies performed with children [48,
49]. Therefore, the present results build on previous know-
ledge in other populations and indicate that replacing IT
with any other activity behaviour has a beneficial impact on
body composition in older adults with an incremental effect
according to the intensity level. Indeed, replacing 30min/
day of IT with equal amounts of time in bed, LPA and
MVPA was associated with a decrease in body fat of −
0.09%, − 0.13% and − 0.54%, respectively. Therefore, these
results showed the close interactions between IT, PA and
health and highlight the need for them to be treated jointly.
These research also highlights that to promote the greater
body composition changes, MVPA is the most effective
form of PA [8, 17, 32, 40, 43, 50], yet increasing LPA in
older adults with chronic conditions would also be of bene-
fit for an improved health profile [13, 40, 47, 51–54]. Over-
all, small beneficial changes in body composition were
observed when replacing IT with time in bed, which is
similar to previous research [32, 52]. Previous research has
shown a link between sleep and obesity [55]; nevertheless,
given the potential measurement errors in the measure-
ment of sleep in our study, further research using gold
standard measures to assess sleep in older adults is needed.
Marked strengths of this study were the use of a longitu-
dinal design in a large cohort of older men and women,
with overweight/obesity and MetS across different com-
munities in Spain using objective measurements. How-
ever, this study involved a homogeneous sample of
Caucasian men and women within narrow ranges of BMI,
age and with worsen metabolic health profile, limiting the
opportunities for extrapolation into other ethnicities and
with healthier individuals. Therefore, it is recommended
for future research to be replicated in different ethnic
groups with different lifestyles and fat distribution. It is
important to highlight the novelty of the present study,
with repeated measures of body composition using gold
standard methods, such as DXA [56, 57], and the meas-
urement of exposure variables with validated question-
naires and with accelerometer data in a subsample.
Several complex and sophisticated statistical analyses were
performed to assess our results. Some limitation to high-
light is the use of questionnaires to obtain data on PA and
SB within the larger sample. Although these were vali-
dated methods and have facilitated access to a larger sam-
ple size, we need to take into account that questionnaires
might be subjected to potential reporting biases. It is im-
portant to mention that the GENEactiv is not able to dif-
ferentiate between sitting and standing position or to
differentiate time in bed from sleeping [29–31]; thus, fur-
ther similar research using other monitors capable to dif-
ferentiate between these behaviours is recommended.
Finally, there was a considerable loss of data from the
DXA scan at 6 and 12months’ visits. Nevertheless, results
were mostly consistent when imputing missing data in
those subjects using the LOCF method.
Conclusions
Results from this longitudinal study indicate that increases
in PA and reductions of SB over 12months follow-up
were associated with an improved body composition pro-
file in older adults with overweight or obesity and MetS.
Replacing IT with any PA and time in bed were associated
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with improvements in body composition. Based on the
present results, the promotion of MVPA would provide
the greatest health benefits in older adults, followed by
LPA. Taking this into account, interventions promoting
LPA might be more appealing in terms of feasibility and
sustainability, as it will help increase attrition rates and re-
duce participant and delivery burden as they will not need
continuous supervision, making them a low-cost and easy
option to be implemented at home or care homes. Future
intervention trials are needed to confirm causality of the
effect of PA and SB on body composition changes in older
adults with chronic conditions.
Supplementary Information
The online version contains supplementary material available at https://doi.
org/10.1186/s12916-020-01847-9.
Additional file 1: Table S1. Socio-demographic, lifestyle and body
composition characteristics of participants at baseline, 6 and 12 months
follow-up in a subsample of participants with accelerometer data avail-
able. Table S2. Association of concurrent changes in self-reported leisure
time physical activity and sedentary behaviour in accumulated incre-
ments of 30 minutes with body composition: longitudinal analysis with
last observation carried forward method. Table S3. Isotemporal substitu-
tion of inactive time (30 min/day) with time in bed and physical activity
measured with accelerometer in body composition changes: longitudinal
analyses with last observation carried forward method. Table S4. Associ-
ation of concurrent changes in self-reported leisure time physical activity
and sedentary behaviour in accumulated increments of 30 minutes with
body composition in a subsample of 388 participants: analyses in
completers-only.
Additional file 2. List of PREDIMED-Plus study investigators.
Abbreviations
BMI: Body mass index; CVD: Cardiovascular disease; DXA: Dual-energy X-ray
absorptiometry; erMedDiet: Energy-restricted traditional Mediterranean diet;
HbA1c: Glycated haemoglobin; ISM: Isotemporal substitution model;
IT: Inactive time; LOCF: Last observation carried forward; LPA: Light physical
activity; MET: Metabolic equivalent task; MetS: Metabolic syndrome;
MVPA: Moderate-to-vigorous physical activity; PA: Physical activity;
SB: Sedentary behaviour; SD: Standard deviation; T2D: Type 2 diabetes;
VAT: Visceral adipose tissue
Acknowledgements
The authors thank the participants for their enthusiastic collaboration and
the PREDIMED-Plus personnel and investigators, as well as all affiliated
primary care centres, for their excellent work.
Authors’ contributions
AMGP, JK and DR conceived the study. AMGP, JK and DR completed the
statistical analysis. AMGP, JK, VVM and DR drafted the manuscript. DR
supervised the study. All authors were involved in the oversight of the
recruitment, data collection, revision of the manuscript and read and
approved the final manuscript.
Funding
The PREDIMED-Plus trial was supported by the official funding agency for
biomedical research of the Spanish government, ISCIII through the Fondo de
Investigación para la Salud (FIS), which is co-funded by the European Re-
gional Development Fund (four coordinated FIS projects led by Jordi Salas-
Salvadó and Josep Vidal, including the following projects: PI13/00673, PI13/
00492, PI13/00272, PI13/01123, PI13/00462, PI13/00233, PI13/02184, PI13/
00728, PI13/01090, PI13/01056, PI14/01722, PI14/00636, PI14/00618, PI14/
00696, PI14/01206, PI14/01919, PI14/00853, PI14/01374, PI16/00473, PI16/
00662, PI16/01873, PI16/01094, PI16/00501, PI16/00533, PI16/00381, PI16/
00366, PI16/01522, PI16/01120, PI17/00764, PI17/01183, PI17/00855, PI17/
01347, PI17/00525, PI17/01827, PI17/00532, PI17/00215, PI17/01441, PI17/
00508, PI17/01732, PI17/00926); the Especial Action Project entitled Imple-
mentación y evaluación de una intervención intensiva sobre la actividad
física Cohorte PREDIMED-Plus grant to Jordi Salas-Salvadó; the Recercaixa
grant to Jordi Salas-Salvadó (2013ACUP00194); grants from the Consejería de
Salud de la Junta de Andalucía (PI0458/2013; PS0358/2016; PI0137/2018); the
PROMETEO/2017/017 grant from the Generalitat Valenciana; the Astra Zeneca
Young Investigators Award in Category of Obesity and Diabetes 2017 to
Dora Romaguera; the ‘FOLIUM’ programme within the FUTURMed project
from the Fundación Instituto de Investigación Sanitaria Illes Balears (financed
by 2017annual plan of the sustainable tourism tax and at 50% with charge
to the ESF Operational Program 2014–2020 of the Balearic Islands) to Jad-
wiga Konieczna. JR17/00022 contract to Olga Castaner from ISCIII. CIBERobn
(Centros de Investigación Biomedica en Red: Obesidad y Nutrición), CIBEResp
(Centros de Investigación Biomedica en Red: Epidemiología y Salud Publica)
and CIBERdem (Centros de Investigación Biomedica en Red: Diabetes y Enfer-
medades). J. Salas-Salvadó author gratefully acknowledges the financial sup-
port by ICREA under the ICREA Academia programme. None of the funding
sources took part in the design, collection, analysis or interpretation of the
data and in writing the manuscript or in the decision to submit the manu-
script for publication.
Availability of data and materials
There are restrictions on the availability of data for the PREDIMED-Plus trial,
due to the signed consent agreements around data sharing, which only
allow access to external researchers for studies following the project
purposes. Requestors wishing to access the PREDIMED-Plus trial data used in
this study can make a request to the PREDIMED-Plus trial Steering
Committee chair: jordi.salas@urv.cat. The request will then be passed to
members of the PREDIMED-Plus Steering Committee for deliberation.
Ethics approval and consent to participate
Research Ethics Committees from all recruitment centres approved the study
protocol, according to the ethical standards of the Declaration of Helsinki. All
participants provided written informed consent. All centres have the ethics
approval and consent from all the ethic committees: CEI de la Universidad
de Navarra, CEIC de León, CEI de las Illes Balears, CEIC del Hospital Clínic de




The authors declare that they have no competing interests.
Author details
1Consorcio CIBER, M.P. Fisiopatología de la Obesidad y la Nutrición
(CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain. 2Research
Group on Nutritional Epidemiology & Cardiovascular Physiopathology
(NUTRECOR), Health Research Institute of the Balearic Islands (IdISBa),
University Hospital Son Espases (HUSE), Palma de Mallorca, Spain. 3School of
Sport, Exercise and Health Science, Loughborough University,
Loughborough, UK. 4Department of Nutrition, Food Sciences and Physiology,
Center for Nutrition Research, University of Navarra, Pamplona, Spain.
5Navarra Institute for Health Research (IdiSNA), University of Navarra,
Pamplona, Spain. 6Universitat Rovira i Virgili, Departament de Bioquímica i
Biotecnologia, Unitat de Nutrició Humana, Reus, Spain. 7Institut d’Investigació
Sanitària Pere Virgili (IISPV), Hospital Universitari San Joan de Reus, Reus,
Spain. 8Instituto de Biomedicina (IBIOMED), University of León, León, Spain.
9Department of Internal Medicine, Institut d’Investigacions Biomèdiques
August Pi Sunyer (IDIBAPS), Hospital Clinic, University of Barcelona, Barcelona,
Spain. 10Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS),
Barcelona, Spain. 11Department of Preventive Medicine and Public Health,
IDiSNA, University of Navarra, Pamplona, Spain. 12ABS Reus V. Centre
d’Assistència Primària Marià Fortuny, SAGESSA, Reus, Spain. 13Unit of
Cardiovascular Risk and Nutrition, Institut Hospital del Mar d’Investigacions
Mèdiques (IMIM), Barcelona, Spain. 14Research Group in Gene-Environment
Interactions and Health, Instituto de Biomedicina (IBIOMED), University of
León, León, Spain. 15CIBER Diabetes y Enfermedades Metabólicas (CIBERDEM),
Instituto de Salud Carlos III (ISCIII), Madrid, Spain. 16Endocrinology and
Galmes-Panades et al. BMC Medicine            (2021) 19:3 Page 9 of 11
Nutrition Department, Obesity Unit, Hospital Clinic, Barcelona, Spain.
17Primary Health Care, Servicio Navarro de Salud, Navarra, Spain. 18School of
Health Sciences, University of Málaga-Institute of Biomedical Research in
Malaga (IBIMA), Málaga, Spain. 19Precision Nutrition and Cardiometabolic
Health program, IMDEA Food, CEI UAM + CSIC, Madrid, Spain.
Received: 23 July 2020 Accepted: 9 November 2020
References
1. Stamatakis E, Gale J, Bauman A, Ekelund U, Hamer M, Ding D. Sitting time,
physical activity, and risk of mortality in adults. J Am Coll Cardiol. 2019;73:
2062–72.
2. Rosique-Esteban N, Díaz-López A, Martínez-González MA, Corella D, Goday
A, Martínez JA, et al. Leisure-time physical activity, sedentary behaviors,
sleep, and cardiometabolic risk factors at baseline in the PREDIMED-Plus
intervention trial: a cross-sectional analysis. PLoS One. 2017;12:e0172253.
3. Galmes-Panades AM, Konieczna J, Abete I, Colom A, Rosique-Esteban N,
Zulet MA, et al. Lifestyle factors and visceral adipose tissue: results from the
PREDIMED-Plus study. PLoS One. 2019;14:1–15.
4. Yates T, Henson J, Edwardson C, Dunstan D, Bodicoat DH, Khunti K, et al.
Objectively measured sedentary time and associations with insulin
sensitivity: importance of reallocating sedentary time to physical activity.
Prev Med. 2015;76:79–83.
5. Lee I-M, Shiroma EJ, Lobelo F, Puska P, Blair SN, Katzmarzyk PT. Effect of
physical inactivity on major non-communicable diseases worldwide: an
analysis of burden of disease and life expectancy. Lancet. 2012;380:219–29.
6. González N, Moreno-Villegas Z, González-Bris A, Egido J, Lorenzo Ó.
Regulation of visceral and epicardial adipose tissue for preventing
cardiovascular injuries associated to obesity and diabetes. Cardiovasc
Diabetol. 2017;16:44.
7. Abete I, Konieczna J, Zulet MA, Galmés-Panades AM, Ibero-Baraibar I, Babio
N, et al. Association of lifestyle factors and inflammation with sarcopenic
obesity: data from the PREDIMED-Plus trial. J Cachexia Sarcopenia Muscle.
2019;10:974–84.
8. Vissers D, Hens W, Taeymans J, Baeyens J-P, Poortmans J, Van Gaal L. The
effect of exercise on visceral adipose tissue in overweight adults: a
systematic review and meta-analysis. PLoS One. 2013;8:e56415.
9. Smith L, Fisher A, Hamer M. Television viewing time and risk of incident
obesity and central obesity: the English longitudinal study of ageing. BMC
Obes. 2015;2:12.
10. An K-Y, Kim S, Oh M, Lee H-S, Yang HI, Park H, et al. Cardiopulmonary
fitness but not muscular fitness associated with visceral adipose tissue mass.
Arch Physiol Biochem. 2019:1–6.
11. Schröder H, Cárdenas-Fuentes G, Martínez-González MA, Corella D, Vioque J,
Romaguera D, et al. Effectiveness of the physical activity intervention
program in the PREDIMED-Plus study: a randomized controlled trial. Int J
Behav Nutr Phys Act. 2018;15:110.
12. Swainson MG, Batterham AM, Hind K. Age- and sex-specific reference
intervals for visceral fat mass in adults. Int J Obes. 2020;44:289–96.
13. Colley RC, Michaud I, Garriguet D. Reallocating time between sleep,
sedentary and active behaviours: associations with obesity and health in
Canadian adults. Health Rep. 2018;29:3–13.
14. Lerma NL, Cho CC, Swartz AM, Miller NE, Keenan KG, Strath SJ. Isotemporal
substitution of sedentary behavior and physical activity on function. Med
Sci Sport Exerc. 2018;50:792–800.
15. Pelclová J, Štefelová N, Dumuid D, Pedišić Ž, Hron K, Gába A, et al. Are
longitudinal reallocations of time between movement behaviours
associated with adiposity among elderly women? A compositional
isotemporal substitution analysis. Int J Obes. 2020;44:857–64.
16. Konieczna J, Abete I, Galmés AM, Babio N, Colom A, Zulet MA, et al.
Body adiposity indicators and cardiometabolic risk: cross-sectional
analysis in participants from the PREDIMED-Plus trial. Clin Nutr. 2019;38:
1883–91.
17. Wander PL, Boyko EJ, Leonetti DL, McNeely MJ, Kahn SE, Fujimoto WY.
Change in visceral adiposity independently predicts a greater risk of
developing type 2 diabetes over 10 years in Japanese Americans. Diabetes
Care. 2013;36:289–93.
18. Després J-P. Body fat distribution and risk of cardiovascular disease.
Circulation. 2012;126:1301–13.
19. Mekary R, Ding E. Isotemporal substitution as the gold standard model for
physical activity epidemiology: why it is the most appropriate for activity
time research. Int J Environ Res Public Health. 2019;16:797.
20. Mekary RA, Willett WC, Hu FB, Ding EL. Isotemporal substitution paradigm
for physical activity epidemiology and weight change. Am J Epidemiol.
2009;170:519–27.
21. Sánchez-Sánchez JL, Mañas A, García-García FJ, Ara I, Carnicero JA, Walter S,
et al. Sedentary behaviour, physical activity, and sarcopenia among older
adults in the TSHA: isotemporal substitution model. J Cachexia Sarcopenia
Muscle. 2019;10:188–98.
22. Grgic J, Dumuid D, Bengoechea EG, Shrestha N, Bauman A, Olds T, et al.
Health outcomes associated with reallocations of time between sleep,
sedentary behaviour, and physical activity: a systematic scoping review of
isotemporal substitution studies. Int J Behav Nutr Phys Act. 2018;15:69.
23. Salas-Salvadó J, Díaz-López A, Ruiz-Canela M, Basora J, Fitó M, Corella D,
et al. Effect of a lifestyle intervention program with energy-restricted
Mediterranean diet and exercise on weight loss and cardiovascular risk
factors: one-year results of the PREDIMED-Plus trial. Diabetes Care. 2018;42:
dc180836.
24. Martínez-González MA, Buil-Cosiales P, Corella D, Bulló M, Fitó M, Vioque J,
et al. Cohort profile: design and methods of the PREDIMED-Plus
randomized trial. Int J Epidemiol. 2019;48:387–388o.
25. Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA,
et al. Harmonizing the metabolic syndrome: a joint interim statement of the
International Diabetes Federation Task Force on Epidemiology and
Prevention; National Heart, Lung, and Blood Institute; American Heart
Association; World Heart Federation; International. Circulation. 2009;120:
1640–5.
26. Molina L, Sarmiento M, Peñafiel J, Donaire D, Garcia-Aymerich J, Gomez M,
et al. Validation of the REGICOR Short Physical Activity questionnaire for the
adult population. PLoS One. 2017;12:1–14.
27. Martínez-González MA, López-Fontana C, Varo JJ, Sánchez-Villegas A,
Martinez JA. Validation of the Spanish version of the physical activity
questionnaire used in the Nurses’ Health Study and the Health
Professionals’ Follow-up Study. Public Health Nutr. 2005;8:920–7.
28. Ainsworth BE, Haskell WL, Herrmann SD, Meckes N, Bassett DR, Tudor-Locke
C, et al. 2011 compendium of physical activities. Med Sci Sport Exerc. 2011;
43:1575–81.
29. Rowlands AV, Mirkes EM, Yates T, Clemes S, Davies M, Khunti K, et al.
Accelerometer-assessed physical activity in epidemiology. Med Sci Sport
Exerc. 2018;50:257–65.
30. Hildebrand M, Van Hees VT, Hansen BH, Ekelund U. Age group
comparability of raw accelerometer output from wrist- and hip-worn
monitors. Med Sci Sport Exerc. 2014;46:1816–24.
31. van Hees VT, Sabia S, Jones SE, Wood AR, Anderson KN, Kivimäki M, et al.
Estimating sleep parameters using an accelerometer without sleep diary. Sci
Rep. 2018;8:12975.
32. Galmes-Panades AM, Varela-Mato V, Konieczna J, Wärnberg J, Martínez-González
MÁ, Salas-Salvadó J, et al. Isotemporal substitution of inactive time with physical
activity and time in bed: cross-sectional associations with cardiometabolic health in
the PREDIMED-Plus study. Int J Behav Nutr Phys Act. 2019;16:137.
33. Kaul S, Rothney MP, Peters DM, Wacker WK, Davis CE, Shapiro MD, et al.
Dual-energy X-ray absorptiometry for quantification of visceral fat. Obesity.
2012;20:1313–8.
34. Fernández-Ballart JD, Piñol JL, Zazpe I, Corella D, Carrasco P, Toledo E, et al.
Relative validity of a semi-quantitative food-frequency questionnaire in an
elderly Mediterranean population of Spain. Br J Nutr. 2010;103:1808–16.
35. Moreiras O, Carbajal A, Cabrera L Cuadrado C. Tablas de composición de
alimentos “Food Composition Table.” 16ª ed. Madrid: Pirámide,. 2013.
36. World Health Organization. Physical activity and older adults. Phys. Act.
Older Adults. 2018. Available from: http://www.who.int/mediacentre/
factsheets/fs385/en/.




38. Piercy KL, Troiano RP, Ballard RM, Carlson SA, Fulton JE, Galuska DA, et al.
The physical activity guidelines for Americans. Jama. 2018;320:2020–8.
39. Dumuid D, Pedišić Ž, Stanford TE, Martín-Fernández J-A, Hron K, Maher CA,
et al. The compositional isotemporal substitution model: a method for
estimating changes in a health outcome for reallocation of time between
Galmes-Panades et al. BMC Medicine            (2021) 19:3 Page 10 of 11
sleep, physical activity and sedentary behaviour. Stat Methods Med Res.
2019;28:846–57.
40. Jefferis BJ, Parsons TJ, Sartini C, Ash S, Lennon LT, Wannamethee SG, et al.
Does duration of physical activity bouts matter for adiposity and metabolic
syndrome? A cross-sectional study of older British men. Int J Behav Nutr
Phys Act; 2016;13:36.
41. Whitaker kara M, Pereira MA, Jacobs DR, Sidney S, Odegaard AO. Sedentary
behavior, physical activity, and abdominal adipose tissue deposition. Med
Sci Sport Exerc. 2017;49:450–8.
42. Irving BA, Davis CK, Brock DW, Weltman JY, Swift D, Barrett EJ, et al. Effect of
exercise training intensity on abdominal visceral fat and body composition.
Med Sci Sport Exerc. 2008;40:1863–72.
43. Murabito JM, Pedley A, Massaro JM, Vasan RS, Esliger D, Blease SJ, et al.
Moderate-to-vigorous physical activity with accelerometry is associated
with visceral adipose tissue in adults. J Am Heart Assoc.
2015;4:e001379.
44. Buman MP, Winkler EAH, Kurka JM, Hekler EB, Baldwin CM, Owen N, et al.
Reallocating time to sleep, sedentary behaviors, or active behaviors:
associations with cardiovascular disease risk biomarkers, NHANES 2005–
2006. Am J Epidemiol. 2014;179:323–34.
45. Swindell N, Rees P, Fogelholm M, Drummen M, MacDonald I, Martinez JA,
et al. Compositional analysis of the associations between 24-h movement
behaviours and cardio-metabolic risk factors in overweight and obese
adults with pre-diabetes from the PREVIEW study: cross-sectional baseline
analysis. Int J Behav Nutr Phys Act. 2020;17:29.
46. Gupta N, Heiden M, Aadahl M, Korshøj M, Jørgensen MB, Holtermann A.
What is the effect on obesity indicators from replacing prolonged sedentary
time with brief sedentary bouts, standing and different types of physical
activity during working days? A cross-sectional accelerometer-based study
among blue-collar workers. PLoS One. 2016;11:e0154935.
47. Dahl-Petersen IK, Brage S, Bjerregaard P, Tolstrup JS, Jørgensen ME. Physical
activity and abdominal fat distribution in Greenland. Med Sci Sport Exerc.
2017;49:2064–70.
48. Leppanen MH, Henriksson P, Delise NC, Henriksson H, Ortega FB, Pomeroy J,
et al. Longitudinal physical activity, body composition, and physical fitness
in preschoolers. Med Sci Sport Exerc. 2017;49:2078–85.
49. Loprinzi PD, Loenneke JP. Mortality risk and perceived quality of life as a
function of waking time in discretionary movement-based behaviors:
isotemporal substitution effects. Qual Life Res. 2017;26:343–8.
50. Dahl-Petersen IK, Bjerregaard P, Brage S, Jørgensen ME. Physical activity
energy expenditure is associated with 2-h insulin independently of obesity
among Inuit in Greenland. Diabetes Res Clin Pract. 2013;102:242–9.
51. Falconer CL, Page AS, Andrews RC, Cooper AR. The potential impact of
displacing sedentary time in adults with type 2 diabetes. Med Sci Sports
Exerc. 2015;47:2070–5.
52. Chastin SFM, Buck C, Freiberger E, Murphy M, Brug J, Cardon G, et al.
Systematic literature review of determinants of sedentary behaviour in older
adults: a DEDIPAC study. Int J Behav Nutr Phys Act. 2015;12:1–12.
53. Hamer M, Stamatakis E, Steptoe A. Effects of substituting sedentary time
with physical activity on metabolic risk. Med Sci Sports Exerc. 2014;46:1946–
50.
54. Ekelund U, Tarp J, Steene-Johannessen J, Hansen BH, Jefferis B, Fagerland
MW, et al. Dose-response associations between accelerometry measured
physical activity and sedentary time and all cause mortality: systematic
review and harmonised meta-analysis. BMJ. 2019;l4570.
55. Beccuti G, Pannain S. Sleep and obesity. Curr Opin Clin Nutr Metab Care.
2011;14:402–12.
56. Mellis MG, Oldroyd B, Hind K. In vivo precision of the GE Lunar iDXA for the
measurement of visceral adipose tissue in adults: the influence of body
mass index. Eur J Clin Nutr. 2014;68:1365–7.
57. Carver TE, Court O, Christou NV, Reid RER, Andersen R. Precision of the iDXA
for visceral adipose tissue measurement in severely obese patients. Med Sci
Sport Exerc. 2014;46:1462–5.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Galmes-Panades et al. BMC Medicine            (2021) 19:3 Page 11 of 11
